United Therapeutics Chairperson and CEO Martine Rothblatt disposes of USD 4.93 million in common sharesPUBT·1 day ago, 03:31 PMUTHR-0.20%
United Therapeutics Corporation $UTHR Shares Sold by KBC Group NVMarket Beat·2 days ago, 04:06 AMUTHR-0.20%
Bowen Hanes & Co. Inc. Makes New Investment in United Therapeutics Corporation $UTHRMarket Beat·2 days ago, 03:08 AMUTHR-0.20%
United Therapeutics director Victor J. Dzau files initial beneficial ownership statementPUBT·2 days ago, 03:48 PMUTHR-0.20%
United Therapeutics CEO Martine A. Rothblatt disposes of 8,500 common shares worth $4.53 millionPUBT·2 days ago, 03:36 PMUTHR-0.20%
United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directors | UTHR Stock NewsStockTitan·Jul 22 at 09:30 PMUTHR-0.20%
United Therapeutics Chairperson, CEO Martine Rothblatt reports disposal of 9,500 common shares worth $5.04 millionPUBT·Jul 22 at 03:31 PMUTHR-0.20%
Analyst Raises Liquidia Price Target from $71 to $101 on Strengthened Legal Position and Yutrepia AdoptionTip Ranks·Jul 22 at 03:05 PMLQDA-3.16%UTHR-0.20%
United Therapeutics updates financial calendar ahead of quarterly results release, webcastPUBT·Jul 22 at 06:00 AMUTHR-0.20%
United Therapeutics Chairperson, CEO Martine Rothblatt reports sale of 9,500 shares for $5.03 millionPUBT·Jul 21 at 03:36 PMUTHR-0.20%
United Therapeutics CEO Martine Rothblatt reports $ 4.45 million common share disposalPUBT·Jul 20 at 03:33 PMUTHR-0.20%
United Therapeutics CEO Martine Rothblatt reports UTHR common share sale worth $4.97 millionPUBT·Jul 17 at 03:31 PMUTHR-0.20%
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) StockMarket Beat·Jul 15 at 03:22 AMUTHR-0.20%
